5-2 承保範圍及不保事項 - ACE Group

1. There is no coverage or payment obligation under this policy to the extent, and only to theextent, that we are prohibited from providing such coverage or making such payment by any type oftrade restriction, economic sanction, or embargo imposed by thegovernment of the United States of America.2. There is no coverage or payment obligation under this policy forany claim actually or allegedly, directly or indirectly, based upon,arising out of, or attributable to any activity or transaction that isprohibited by any type of travel restriction, trade restriction, economicsanction, or embargo imposed by the government of the United Statesof America.3. However, paragraphs 1. and 2. of this provision shall not apply to any action or transaction forwhich the Named Insured has received a special license from the government of the United States ofAmerica, provided that we receive a copy of such license.E. Other Insurance1. If other valid and collectible insurance is available to the insured for a loss we cover under thisHUMAN CLINICAL TRIALS LIABILITY COVERAGE part, our obligations are limited as follows:a. Primary InsuranceThis insurance is primary except when the provisions of Paragraph b. below apply or when the terms orconditions of that other insurance or any “underlyer policy” do not apply to a loss covered by thisinsurance. If this insurance is primary, our obligations are not affected unless any of the other insurance isalso primary. Then, we will share with all that other insurance by the method described in f. below.b. Excess Insurance(1) This insurance is excess over:(a) Any other insurance, whether primary, excess, contingent or on any other basis that is effectiveprior to the beginning of the policy period shown in the Declarations of this insurance and applies to “bodilyinjury” or “property damage” on other than a claims-made basis, if:i. No Retroactive Date is shown in the Schedule above; orii. The other insurance has a policy period which continues after theRetroactive Date shown in the Schedule above; or178